RT Journal Article
SR Electronic
T1 Virtual care with digital technologies for rural and remote Canadians living with cardiovascular disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.17.20248333
DO 10.1101/2020.12.17.20248333
A1 Ryan Buyting
A1 Sarah Melville
A1 Hanif Chatur
A1 Christopher W. White
A1 Jean-François Légaré
A1 Sohrab Lutchmedial
A1 Keith R. Brunt
YR 2020
UL http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248333.abstract
AB Canada is a wealthy nation with a geographically diverse population, seeking health innovations to better serve patients in accordance with the Canada Health Act. In this country, population and geography converge with social determinants, policy, procurement regulations, and technological advances, in order to achieve equity in the management and distribution of healthcare. Rural and remote patients are a vulnerable population; when managing chronic conditions such as cardiovascular disease, there is inequity when it comes to accessing specialist physicians at the recommended frequency—increasing the likelihood of poor health outcomes. Ensuring equitable care for this population is an unrealized priority of several provincial and federal government mandates. Virtual care technology may provide practical, economical, and innovative solutions to remedy this discrepancy. Here we review the literature pertaining to the use of virtual care technologies to monitor patients with cardiovascular disease living in rural areas of Canada. A search strategy was developed to identify the literature specific to this context across three bibliographic databases. 166 unique citations were ultimately assessed for eligibility, of which 36 met the inclusion criteria. In our assessment of these articles, we provide a summary of the interventions studied, their reported effectiveness in reducing adverse events and mortality, the challenges to implementation, and the receptivity of these technologies amongst patients, providers and policy makers. Further, we glean insight into the barriers and opportunities to ensure equitable care for rural patients and conclude that there is an ongoing need for clinical trials assessing virtual care technologies in this context.Summary Patients living in rural and remote communities’ experience diverse challenges to receiving equitable healthcare as is mandated by the Canada Health Act. Advances in virtual care technology may provide practical, economical, and innovative solutions to ensure this for patients in remote and rural living situations. Here we provide a state-of-the-art review of virtual care technologies available to patients with cardiovascular disease living in rural areas of Canada.Competing Interest StatementKRB has a direct financial interest in medical technology innovation companies as a director or shareholder of: NBBM Inc. and Routinify Inc.; has received partnership grant/contract funding or financial in-kind support from or serves as a medical science advisor to: Ausculsciences Inc.; BaioTeq Inc.; Cloud-Dx Inc.; eVisitNB (Maple Inc.); Medtronic Canada Inc.; Serviere Canada Inc.; IBM Canada; and the Government of New Brunswick. HC has a direct financial interest in medical technology innovation companies as a director or shareholder of eVisitNB (Maple Inc.) JFL and SL have received medical technology innovation partnership grant/contract funding or financial in-kind support from Medtronic Inc.; Serviere Canada Inc. RB, SM, and CWW have no conflicts of interest to disclose relevant to the present work. None of these enterprises played a role in the design, data collection, analysis, or interpretation of this literature review, or in preparation of this manuscript.Funding StatementThis work was generously supported by AGE-WELL NCE Inc., a member of the Networks of Centres of Excellence program, the New Brunswick Health Research Foundation and the New Brunswick Innovation Foundation. Neither of these organizations played a role in the design, data collection, analysis, or interpretation of this literature review, or in preparation of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethics approval was needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo datasets were generated or analyzed during the current study.